Poststroke Depression

REFERENCES

• Kaplan A. Neuropsychiatric symptoms in post-stroke patients. Psychiatric Times. 2005;22.
   Google Scholar
• Whyte EM, Mu!sant BH, Vanderbilt J, Dodge HH, Ganguli M. Depression after stroke: a prospective epidemiological study. J Am Geriatr Soc. 2004;52(5):774–778.
   PubMed Web of Science ®Google Scholar
• Ramasubbu R, Robinson RG, Flint AJ, Kosier T, Price TR. Functional impairment associated with acute poststroke depression: the Stroke Data Bank Study. L Neuropsychiatry Clin Neurosci. 1998;10(1):26–33.
   PubMed Web of Science ®Google Scholar
• Whyte EM, Mulsant BH. Post stroke depression: epi-demiology, pathophysiology, and biological treat-ment. Biol Psychiatry. 2002;52(3):253–264.
   PubMed Web of Science ®Google Scholar
• Astrom M, Adolfsson R, Asplund K. Major depression in stroke patients. A 3-year longitudinal study. Stroke. 1993;24(7):976–982.
   PubMed Web of Science ®Google Scholar
• Everson SA, Roberts RE, Goldberg DE, Kaplan GA. Depressive symptoms and increased risk of stroke mortality over a 29-year period. Arch Intern Med. 1998;158(10):1133–1138.
   PubMed Web of Science ®Google Scholar
• Robinson RG, Bolduc PL, Price TR. Two-year longitu-dinal study of poststroke mood disorders: diagnosis and outcome at one and two years. Stroke. 1987;18(5):837–843.
   PubMed Web of Science ®Google Scholar
• Simonsick EM, Wallace RB, Blazer DG, Berkman LF. Depressive symptomatology and hypertension-as-sociated morbidity and mortality in older adults. Psychosom Med. 1995;57(5):427–435.
   PubMed Web of Science ®Google Scholar
• Alexopoulos GS, Meyers BS, Young RC, Kakuma T, Silbersweig D., Char!son M. Clinically defined vascu-lar depression. Am J Psychiatry. 1997;154(4):562–565.
   PubMed Web of Science ®Google Scholar
• Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D., Char!son M. "Vascular depression" hypothesis. Arch Gen Psychiatry. 1997;54(10):915–922.
   PubMed Web of Science ®Google Scholar
• Pohjasvaara T, Vataja R, Leppavuori A, Kaste M, Erkinjuntti T. Depression is an independent predic-tor of poor long-term functional outcome post-stroke. Eur J Neurol. 2001;8(4):315–319.
   PubMed Web of Science ®Google Scholar
• Singh A, Black SE, Herrmann N, et al. Functional and neuroanatomic correlations in poststroke depres-sion: the Sunnybrook Stroke Study. Stroke. 2000;31(3):637–644.
   PubMed Web of Science ®Google Scholar
• Kotila M, Numminen H, Waltimo O, Kaste M. De-pression after stroke: results of the FINNSTROKE Study. Stroke. 1998;29(2):368–372.
   PubMed Web of Science ®Google Scholar
• Berg A, Palomaki H, Lehtihalmes M, Lonnqvist J, Kaste M. Poststroke depression: an 18-month fol-low-up. Stroke. 2003;34(1):138–143.
   PubMed Web of Science ®Google Scholar
• Mast BT. Cerebrovascular disease and late-life depres-sion: a latent-variable analysis of depressive symp-toms after stroke. Am J Geriatr Psychiatry. 2004;12(3):315–322.
   PubMed Web of Science ®Google Scholar
• Paolucci S, Gandolfo C, Provinciali L, Torta R, Toso V. The Italian multicenter observational study on post-stroke depression (DESTRO). J Neurol. 2006;253(5):556–562.
   PubMed Web of Science ®Google Scholar
• Larson SL, Owens PL, Ford D, Eaton W. Depressive disorder, dysthymia, and risk of stroke: thirteen-year follow-up from the Baltimore epidemiologic catch-ment area study. Stroke. 2001;32(9):1979–1983.
   PubMed Web of Science ®Google Scholar
• Pohjasvaara T, Erkinjuntti T, Ylikoski R, Hietanen M, Vataja R, Kaste M. Clinical determinants of poststroke dementia. Stroke. 1998;29(1):75–81.
   PubMed Web of Science ®Google Scholar
• Schubert DS, Burns R, Paras W, Sioson E. Increase of medical hospital length of stay by depression in stroke and amputation patients: a pilot study. Psychother Psychosom. 1992;57(1-2):61–66.
   PubMed Web of Science ®Google Scholar
• Jonas BS, Mussolino ME. Symptoms of depression as a prospective risk factor for stroke Psychosom Med. 2000;62(4):463–471.
   PubMed Web of Science ®Google Scholar
• Ohira T, Lso H, Satoh S, et al. Prospective study of depressive symptoms and risk of stroke among Japa-nese. Stroke. 2001;32(4):903–908.
   PubMed Web of Science ®Google Scholar
• Robinson RG, Starr LB, Price TR. A two year longitudi-nal study of mood disorders following stroke. Preva-lence and duration at six months follow-up. Br Psychiatry. 1984;144:256–262.
   PubMed Web of Science ®Google Scholar
• Robinson RG, Starkstein SE, Price TR. Post-stroke de-pression and lesion location. Stroke. 1988;19(1):125–126.
   PubMed Web of Science ®Google Scholar
• Starkstein SE, Cohen BS, Fedoroff P, Parikh RM, Price TR, Robinson RG. Relationship between anxiety disor-ders and depressive disorders in patients with cere-brovascular injury. Arch Gen Psychiatry. 1990;47(3):246–251.
   PubMed Web of Science ®Google Scholar
• Starkstein SE, Robinson RG, Berthier ML, Parikh RM, Price TR. Differential mood changes following basal ganglia vs thalamic lesions. Arch Neurol. 1988;45(7):725–730.
   PubMed Web of Science ®Google Scholar
• Starkstein SE, Robinson RG, Price TR. Comparison of cortical and subcortical lesions in the production of poststroke mood disorders. Brain. 1987;110(Pt 4):1045–1059.
   PubMed Web of Science ®Google Scholar
• Robinson RG, Kubos KL, Starr LB, Rao K, Price TR. Mood changes in stroke patients: relationship to le-sion location. Compr Psychiatry. 1983;24(6):555–566.
   PubMed Web of Science ®Google Scholar
• Bhogal SK, Teasell R, Foley N, Speechley M. Lesion location and poststroke depression: systematic re-view of the methodological limitations in the litera-ture. Stroke. 2004;35(3):794–802.
   PubMed Web of Science ®Google Scholar
• Carson AJ, MacHale S, Allen K, et al. Depression after stroke and lesion location: a systematic review. Lan-cet. 2000;356(9224):122–126.
   PubMed Web of Science ®Google Scholar
• de Groot JC, de Leeuw FE, Oudkerk M, Hofman A, Jolles J, Breteler MM. Cerebral white matter lesions and depressive symptoms in elderly adults. Arch Gen Psychiatry. 2000;57(11):1071–1076.
   PubMed Web of Science ®Google Scholar
• Sachdev PS, Chen X, Joscelyne A, Wen W, Brodaty H. Amygdala in stroke/transient ischemic attack patients and its relationship to cognitive impairment and psy-chopathology: the Sydney Stroke Study. Am J Geriatr Psychiatry. 2007;15(6):487–496.
   PubMed Web of Science ®Google Scholar
• Brodaty H, Withall A, Altendorf A, Sachdev PS. Rates of depression at 3 and 15 months poststroke and their relationship with cognitive decline: the Sydney Stroke Study. Am J Geriatr Psychiatry. 2007;15(6): 477–486.
   PubMed Web of Science ®Google Scholar
• Fujikawa T, Yamawaki S, Touhouda Y. Incidence of silent cerebral infarction in patients with major de-pression. Stroke. 1993;24(11):1631–1634.
   PubMed Web of Science ®Google Scholar
• Heresco-Levy U, Javitt DC. The role of N-methyl-D-aspartate (NMDA) receptor-mediated neurotrans-mission in the pathophysiology and therapeutics of psychiatric syndromes. Eur Neuropsychopharmacol. 1998;8(2):141–152.
   PubMed Web of Science ®Google Scholar
• Glodzik-Sobanska L, Slowik A, McHugh P, et al. Single voxel proton magnetic resonance spectroscopy in post-stroke depression. Psychiatry Res. 2006;148(2-3):111–120.
   PubMed Web of Science ®Google Scholar
• Hickie I, Scott E. Late-onset depressive disorders: a preventable variant of cerebrovascular disease? Psycho! Med. 1998;28(5):1007–1013.
   PubMed Web of Science ®Google Scholar
• Aben I, Verhey F, Strik J, Lousberg R, Lodder J, Honig A. A comparative study into the one year cumulative incidence of depression after stroke and myocardial infarction. J Neurol Neurosurg Psychiatry. 2003; 74(5):581–585.
   PubMed Web of Science ®Google Scholar
• Lyness JM. The cerebrovascular model of depression in late life. CNS Spectr. 2002;7(10):712–715.
   PubMedGoogle Scholar
• Lyness JM, Caine ED, King DA, Conwell Y, Cox C, Duberstein PR. Cerebrovascular risk factors and de-pression in older primary care patients: testing a vascular brain disease model of depression. Am Geriatr Psychiatry. 1999; 7(3):252–258.
   PubMed Web of Science ®Google Scholar
• Steffens DC, Krishnan KR, Crump C, Burke GL. Cere-brovascular disease and evolution of depressive symptoms in the cardiovascular health study. Stroke. 2002;33(6):1636–1644.
   PubMed Web of Science ®Google Scholar
• Holley C, Murrell SA, Mast BT. Psychosocial and vas-cular risk factors for depression in the elderly. Am J Geriatr Psychiatry. 2006;14(1):84–90.
   PubMed Web of Science ®Google Scholar
• Kang Y. Effect of uncertainty on depression in pa-tients with newly diagnosed atrial fibrillation. Prog Cardiovasc Nurs. 2006;21(2):83–88.
   PubMedGoogle Scholar
• Thrall G, Lip GY, Carroll D, Lane D. Depression, anxi-ety and quality of life in patients with atrial fibrillation [Electronic version]. Chest. 2007;132:1259–1264.
   PubMed Web of Science ®Google Scholar
• Barnes DE, Alexopoulos GS, Lopez OL, Williamson JD, Yaffe K. Depressive symptoms, vascular disease, and mild cognitive impairment: findings from the Cardio-vascular Health Study. Arch Gen Psychiatry. 2006;63(3):273–279.
   PubMed Web of Science ®Google Scholar
• Verdelho A, Henon H, Lebert F, Pasquier F, Leys D. Depressive symptoms after stroke and relationship with dementia: a three-year follow-up study. Neurol-ogy. 2004;62(6):905–911.
   PubMed Web of Science ®Google Scholar
• Aben I, Denollet J, Lousberg R, Verhey F, Wojciechowski F, Honig A. Personality and vulnerabil-ity to depression in stroke patients: a 1-year prospec-tive follow-up study. Stroke. 2002;33(10): 2391–2395.
   PubMed Web of Science ®Google Scholar
• Jorge RE, Robinson RG, Arndt S, Starkstein S. Mortal-ity and poststroke depression: a placebo-controlled trial of antidepressants. Am J Psychiatry. 2003;160(10):1823–1829.
   PubMed Web of Science ®Google Scholar
• Herrmann N, Black SE, Lawrence J, Szekely C, Szalai JP. The Sunnybrook Stroke Study: a prospective study of depressive symptoms and functional out-come. Stroke. 1998;29(3):618–624.
   PubMed Web of Science ®Google Scholar
• Angelelli P, Paolucci S, Bivona U, et al. Development of neuropsychiatric symptoms in poststroke pa-tients: a cross-sectional study. Acta Psychiatr Scand. 2004;110(1):55–63.
   PubMed Web of Science ®Google Scholar
• Reynolds CF 3rd, Lebowitz BD, Schneider LS. The NIH Consensus Development Conference on the Diagnosis and Treatment of Depression in Late Life: an overview. Psychopharmacol Bull. 1993;29(1):83–85.
   PubMed Web of Science ®Google Scholar
• Spiller JA, Keen JC. Hypoactive delirium: assessing the extent of the problem for inpatient specialist palliative care. Pa/hat Med. 2006;20(1):17–23.
   Google Scholar
• van de Weg FB, Kuik DJ, Lankhorst Gl. Post-stroke depression and functional outcome: a cohort study investigating the influence of depression on func-tional recovery from stroke. Clin Rehabil. 1999;13(3):268–272.
   PubMed Web of Science ®Google Scholar
• Morris PL, Robinson RG, Samuels J. Depression, in-troversion and mortality following stroke. Aust N Z I Psychiatry. 1993;27(3):443–449.
   PubMed Web of Science ®Google Scholar
• Bourgeois JA, Hilty DM, Chang CH, Wineinger MA, Servis ME. Poststroke neuropsychiatric illness: an integrated approach to diagnosis and management. Curr Treat Options Neurol. 2004;6(5):403–420.
   PubMedGoogle Scholar
• Narushima K, Kosier JT, Robinson RG. Preventing poststroke depression: a 12-week double-blind ran-domized treatment trial and 21-month follow-up. J Nerv Ment Dis. 2002;190(5):296–303.
   PubMed Web of Science ®Google Scholar
• Robinson RG. Neuropsychiatric consequences of stroke. Annu Rev Med. 1997;48:217–229.
   PubMed Web of Science ®Google Scholar
• Lipsey JR, Robinson RG, Pearlson GD, Rao K, Price TR. Nortriptyline treatment of post-stroke depres-sion: a double-blind study. Lancet. 1984;1(8372): 297–300.
   PubMed Web of Science ®Google Scholar
• Andersen G, Vestergaard K, Lauritzen LU. [Effective treatment of depression following apoplexy with citalopram]. Uqeskr Laeqer. 1995;157(14):2000–2003.
   PubMedGoogle Scholar
• Wiart L, Petit H, Joseph PA, Mazaux JM, Barat M. Fluoxetine in early poststroke depression: a double-blind placebo-controlled study. Stroke. 2000;31(8):1829–1832.
   PubMed Web of Science ®Google Scholar
• Robinson RG, Schultz SK, Castillo C, et al. Nortrip-tyline versus fluoxetine in the treatment of depres-sion and in short-term recovery after stroke: a pla-cebo-controlled, double-blind study. Am J Psychiatry. 2000;157(3):351–359.
   PubMed Web of Science ®Google Scholar
• Johnson ML, Roberts MD, Ross AR, Witten CM. Methylphenidate in stroke patients with depression. Am L Phys Med Rehabil. 1992;71(4):239–241.
   PubMed Web of Science ®Google Scholar
• Taragano FE, Allegri R, Vicario A, Bagnatti P, Lyketsos CG. A double blind, randomized clinical trial assessing the efficacy and safety of augmenting standard antidepressant therapy with nimodipine in the treatment of "vascular depression." Intl Geriatr Psychiatry. 2001;16(3):254–260.
   PubMed Web of Science ®Google Scholar
• Kales HC, Maixner DF, Mellow AM. Cerebrovascular disease and late-life depression. Am J Geriatr Psychia-tt_-L 2005;13(2):88–98.
   PubMed Web of Science ®Google Scholar
• Matsuura E, Ohta A, Kanegae F, et al. Frequency and analysis of factors closely associated with the devel-opment of depressive symptoms in patients with scleroderma. J Rheumatol. 2003;30(8):1782–1787.
   PubMed Web of Science ®Google Scholar
• Coleiro B, Marshall SE, Denton CP, et al. Treatment of Raynaud's phenomenon with the selective sero-tonin reuptake inhibitor fluoxetine. Rheumatoloqv (Oxford). 2001;40(9):1038–1043.
   PubMed Web of Science ®Google Scholar
• Ramasubbu R. Cerebrovascular effects of selective serotonin reuptake inhibitors: a systematic review. L Clin Psychiatry. 2004;65(12):1642–1653.
   PubMed Web of Science ®Google Scholar
• Serebruany VL, Glassman AH, Malinin Al, et al. Se-lective serotonin reuptake inhibitors yield additional antiplatelet protection in patients with congestive heart failure treated with antecedent aspirin. Eur J Heart Fail. 2003;5(4):517–521.
   PubMed Web of Science ®Google Scholar